These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9243642)

  • 1. cAMP decreases steady-state levels of delta-opioid receptor mRNA in NG108-15 cells.
    Gylys KH; Tran N; Magendzo K; Zaki P; Evans CJ
    Neuroreport; 1997 Jul; 8(9-10):2369-72. PubMed ID: 9243642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of isobutylmethylxanthine and phosphodiesterase-selective inhibitors on cAMP levels in SH-SY5Y neuroblastoma cells.
    Morgan AJ; Murray KJ; Challiss RA
    Biochem Pharmacol; 1993 Jun; 45(12):2373-80. PubMed ID: 7687130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.
    Wright IK; Amirchetty-Rao S; Kendall DA
    Br J Pharmacol; 1994 Aug; 112(4):1146-50. PubMed ID: 7524992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
    Bergsbaken CL; Sommers SL; Law PY
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1474-83. PubMed ID: 7680718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein kinase A prevents the ethanol-induced up-regulation of delta-opioid receptor mRNA in NG108-15 cells.
    Jenab S; Inturrisi CE
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):44-8. PubMed ID: 9221900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP.
    Altiok N; Fredholm BB
    Neurochem Int; 1992 Sep; 21(2):209-13. PubMed ID: 1284620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
    Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
    Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.
    Hall IP; Widdop S; Townsend P; Daykin K
    Br J Pharmacol; 1992 Oct; 107(2):422-8. PubMed ID: 1384913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY; Loh HH
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
    Yu VC; Eiger S; Duan DS; Lameh J; Sadée W
    J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes.
    Nicholson D; White TD; Sawynok J
    Can J Physiol Pharmacol; 1991 Jun; 69(6):877-85. PubMed ID: 1717120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of rolipram-sensitive phosphodiesterase in rat megakaryocyte.
    Akaike N; Uneyama H; Kawa K; Yamashita Y
    Br J Pharmacol; 1993 Aug; 109(4):1020-3. PubMed ID: 7691362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
    Gordeladze JO
    Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of delta-opioid receptor mRNA levels by receptor-mediated and direct activation of the adenylyl cyclase-protein kinase A pathway.
    Buzas B; Rosenberger J; Cox BM
    J Neurochem; 1997 Feb; 68(2):610-5. PubMed ID: 9003047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
    Zhu WH; Majluf-Cruz A; Omburo GA
    Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the cAMP-elevating effects of isoproterenol and forskolin in cardiac myocytes by treatments that cause increases in cAMP.
    Cui H; Green RD
    Biochem Biophys Res Commun; 2003 Jul; 307(1):119-26. PubMed ID: 12849990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice.
    Fischer W; Schudt C; Wendel A
    Biochem Pharmacol; 1993 Jun; 45(12):2399-404. PubMed ID: 8392340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.